Purchase Order 36C26123P0551
Award Date 1/19/23
Potential Completion Date 4/20/23
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical product UPTRAVI. The $125,284.68 contract supports the delivery of this medication directly to VA medical centers and facilities across the country, including in Palo Alto, California. This order, which does not have a set-aside designation, is part of Accredo Health...
- This is a federal contract award to Accredo Health Group, Inc., a prime contractor, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 21. The award is for the specialty medication UPTRAVI, with a potential value of $104,778.03 and a completion date of September 30, 2021. The contract is a firm fixed price purchase order with no set-aside designation. Accredo Health Group, a for-profit organization, provides specialty pharmacy...
- The Department of Veterans Affairs Veterans Health Administration awarded a $13,557 purchase order to Accredo Health Group, Inc. to deliver TYVASO in Palo Alto, California from January 18, 2023 through April 18, 2023. As a prime contractor supporting VA's Veterans Integrated Service Network 21, Accredo Health Group will provide the pulmonary arterial hypertension medication on a firm fixed price basis. No subcontractors or set aside designations were indicated. This purchase order was issued...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit specialty pharmacy company. The contract is for a 180-day supply of the medication Uptravi 600mcg, with a ceiling value of $78,557.34. The contract is not designated as a set-aside. Accredo Health Group, Inc. is a key distributor of complex and high-value medications to the VA's Veterans Integrated Service Networks (VISNs), with a focus on drugs...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of UPTRAVI 1600MCG, a medication used to treat pulmonary arterial hypertension, under a larger VA contract vehicle (36F79719D0142). The contract has a ceiling value of $166,022.23 and a performance period ending on January 11, 2025. Accredo Health Group, Inc. is a subsidiary of...
- Accredo Health Group, Inc. was awarded a $14,801.97 firm fixed price purchase order without a set-aside designation from the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 4. The contract is for the delivery of specialty pharmaceutical products to support VHA treatment programs for veterans located in Philadelphia, Pennsylvania. As the prime contractor, Accredo Health Group will distribute specialty medications directly to VA medical...
- The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
- Accredo Health Group, Inc. was awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23, valued at $64,907.10, to provide a six month supply of Palynziq 20mg injections for emergency medication orders. Performance will take place at Accredo's distribution center in Bartlett, Tennessee, with no set aside designation used. As a prime contractor supporting the VHA through national contracts and regional...
- This federal contract award is for the purchase of specialty medications by the U.S. Department of Veterans Affairs (VA) from Accredo Health Group, Inc., a specialty pharmacy services provider. The contract award, valued at $2,603.79, is for the delivery of specific high-value medications to VA medical centers and facilities nationwide, supporting the Veterans Health Administration's (VHA) treatment programs. The contract is a firm fixed-price purchase order with no set-aside designation....
- The U.S. Department of Veterans Affairs (VA) awarded a $43,162 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical Prolastin. This contract is not associated with a set-aside program and has an ultimate completion date of June 30, 2024. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily serving the healthcare needs of...